Healthy Clinical Trial
Official title:
Assessing Neurophysiological Markers of Brain Function: Investigating Event-Related Potentials and Eye-Tracking Measures in Hockey Players
NCT number | NCT03975023 |
Other study ID # | Carrick-001 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | July 7, 2019 |
Est. completion date | April 16, 2020 |
Verified date | January 2021 |
Source | Carrick Institute for Graduate Studies |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Traumatic brain injury (TBI) is a health issue impacting athletes and no clinical treatment protocol, other than rest, is yet established. The efficacy of a treatment protocol relies on objective, physiological measures of brain function and ultimately a quantification of injury severity. The present study aims to assess neurophysiological markers of auditory and visual measures of brain function using the NeuroCatch Platform and eye-tracking technology, respectively. The current gold standard of TBI evaluation, including cognitive and balance assessments, will also be captured.
Status | Completed |
Enrollment | 52 |
Est. completion date | April 16, 2020 |
Est. primary completion date | July 11, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 14 Years to 25 Years |
Eligibility | Inclusion Criteria: - Any sex, 14-25 years old inclusively - Attending the Creative Artists Agency LLC (CAA) hockey camp in July 2019 - Able to understand the informed consent/assent form, study procedures and willing to participate in study NeuroCatch Platform-Specific Inclusion Criteria - Able to remain seated and focused for 6 minutes - Normal hearing capabilities Exclusion Criteria: • Unable to provide informed consent NeuroCatch Platform-Specific Exclusion Criteria - Clinically documented hearing issues (e.g. tinnitus, in-ear hearing problems or punctured ear drum) - In-ear hearing aid or cochlear implant, hearing device - Implanted pacemaker or defibrillator - Metal or plastic implants in skull - Exposed to an investigational drug or device 30 days prior to start in this study, or concurrent or planned use of investigational drug or device during hockey camp (July 7th - 13th 2019) - Not proficient in English - Previous exposure to the NeuroCatch™ Platform audio sequences in the last 6 months - History of seizures - Allergy to rubbing alcohol or EEG gel - Unhealthy scalp (apparent open wounds and/or bruised or weakened skin) |
Country | Name | City | State |
---|---|---|---|
United States | The Carrick Institute | Cape Cañaveral | Florida |
Lead Sponsor | Collaborator |
---|---|
Frederick Carrick, PhD, FACCN | HealthTech Connex Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Trends between outcome measures and demographics will be explored | Demographics include age, concussion history, and handedness | 1 year | |
Primary | ERP response size | amplitude in microvolts | 1 week | |
Primary | ERP response timing | latency in milliseconds | 1 week | |
Primary | Eye-tracking: target accuracy | distance in millimeters for each eye | 1 week | |
Primary | Eye-tracking: speed | degrees per second | 1 week | |
Secondary | Cognitive tests | Cognitive assessments will be captured using Cambridge Brain Sciences battery of neuropsychological tests (composite score) and Highmark Interactive's EQ app | 1 year | |
Secondary | Balance | Balance measured in seconds as captured by Highmark Interactive's EQ app | 1 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |